Reversion of pathogenic BRCA1 L1780P mutation confers resistance to PARP and ATM inhibitor in breast cancer von Jo, Se-Young, Lee, Jeong Dong, Won, Jeongsoo, Park, Jiho, Kweon, Taeyong, Jo, Seongyeon, Sohn, Joohyuk, Kim, Seung-Il, Kim, Sangwoo, Park, Hyung Seok

Volltext